FindTrial
Sign In

A STUDY TO COMPARE THE EFFECTIVENESS OF LYCOPUS VIRGINICUS AND INDIVIDUALISED HOMOEOPATHIC MEDICINES FOR HIGH BLOOD PRESSURE (WITHOUT A KNOWN CAUSE) IN PEOPLE AGED 25 TO 60 YEARS

A COMPARATIVE STUDY ON THE EFFECTIVENESS OF LYCOPUS VIRGINICUS AND INDIVIDUALISED HOMOEOPATHIC MEDICINES FOR PRIMARY SYSTEMIC HYPERTENSION IN THE AGE GROUP 25 TO 60 YEARS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107666
Enrollment
62
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: LYCOPUS VIRGINICUS: FIRST PARTICIPANT WILL BE GIVEN LYCOPUS VIRGINICUS IN POTENCIES ALONG WITH ADVICE OF LIFE STYLE MODIFICATIONS LIKE REGULAR EXERCISE, MANAGING STRESS WHO SATISFYING I

Sponsors

KARTHIKA G S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INDIVIDUALS WITH STAGE 1 SYSTEMIC HYPERTENSION(ACCORDING TO WORLD HEALTH ORGANISATION STAGE1 (MILD)SYSTOLIC BLOOD PRESSURE 140-159mmHg, DIASTOLIC BLOOD PRESSURE 90-99mmHg)

Exclusion criteria

Exclusion criteria: CASES OF MALIGNANCIES, PREVIOUS HISTORY OF CARDIAC SURGERY, INDIVIDUALS WHO TAKING ANY OTHER CONVENTIONAL TREATMENT FOR HYPERTENSION, PREGNANT WOMEN AND LACTATING MOTHERS

Design outcomes

Primary

MeasureTime frame
CASES WILL BE REVIEWED AT AN INTERVAL OF 2 WEEK AFTER THE ADMINISTRATION OF LYCOPUS VIRGINICUS AND INDIVIDUALISED HOMOEOPATHIC MEDICINES. OUTCOME WILL ASSESSED FROM BASELINE TO THIRD MONTH AND SIXTH MONTH BY EVALUATING MEAN SYSTOLIC AND MEAN DIASTOLIC BLOOD PRESSURETimepoint: THIRD MONTH AND SIXTH MONTH—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactNISHA M
nisha_nizam@yahoo.com9846319984

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026